Azioni Alexion Pharmaceuticals, Inc.
Azioni
ALXN
US0153511094
Prodotti farmaceutici
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Marc Dunoyer
CEO | Chief Executive Officer | 71 | - |
Sean Christie
DFI | Director of Finance/CFO | - | 01/08/21 |
Chief Tech/Sci/R&D Officer | - | 01/12/20 |
Variaz. 1 gen. | Capi. | |
---|---|---|
+43,64% | 754 Mrd | |
+39,16% | 630 Mrd | |
-6,58% | 352 Mrd | |
+19,72% | 331 Mrd | |
+8,78% | 298 Mrd | |
+11,70% | 217 Mrd | |
-1,76% | 216 Mrd | |
+0,03% | 163 Mrd | |
+6,13% | 164 Mrd |